Vaccines Global Market Opportunities And Strategies To 2031

Jan 2023| TBR595F| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Anti-Infective Vaccines; Anti-Cancer Vaccines
2) By Technology: Conjugate Vaccines; Inactivated And Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines
3) By Route Of Administration: Intramuscular (IM); Subcutaneous (SC); Oral
4) By Valance: Monovalent; Multivalent
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Institutional Sales
Covering: Pfizer Inc.; Merck & Co., Inc.; GlaxoSmithKline plc; Sanofi S.A.; AstraZeneca

Vaccines Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global vaccines market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest-growing market for vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The vaccines market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider vaccines market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics: Brief introduction to the segmentations covered in the market, definitions and explanations about vaccines market.
  • Key Trends: Highlights the major trends shaping the global vaccines market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth: Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis: Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.
  • Market Segmentation: Contains the market values (2016-2031) and analysis for for segment by type, segmentation by technology, segmentation by route of administration, segmentation by valance and segmentation by distribution channel in the market.
  • Regional Market Size and Growth: Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Pipeline Analysis: Briefs on the pipeline analysis of vaccines from the major players in the market.
  • Key Mergers and Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - This section Includes recommendations for vaccines providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2021-2031
Units considered $ Million
Segments covered By Type, By Technology, By Route Of Administration, By Valance, By Distribution Channel
Industry covered Pharmaceuticals
Regions covered Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered China, Australia, India, Indonesia, Japan, South Korea, USA, Brazil, France, Germany, UK, Russia
Companies studied
Pfizer Inc.
Sanofi S.A.
Merck & Co., Inc.
GlaxoSmithKline plc
AstraZeneca

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Type: Anti-Infective Vaccines; Anti-Cancer Vaccines; Other Types
  • By Technology: Conjugate Vaccines; Inactivated And Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines; Other Technologies
  • By Route Of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Other Route of Administration
  • By Valance: Monovalent; Multivalent
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Institutional Sales

Companies Mentioned: Pfizer Inc.; Merck & Co., Inc.; GlaxoSmithKline plc; Sanofi S.A.; AstraZeneca

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; vaccines indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; vaccines market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 2 : Global Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3 : Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4 : Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5 : Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6 : Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7 : Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10 : Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11 : Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12 : Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13 : Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 14 : Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 15 : Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 16 : Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 17 : Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 18 : Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 19 : Asia-Pacific Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 20 : Asia-Pacific Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 21 : Asia-Pacific Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 22 : Asia-Pacific Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 23 : Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 24 : Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 25 : Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 26 : Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 27 : Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 28 : Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 29 : China GDP Per Capita, 2016-2021, $
  • Table 30 : China Population By Age Group, 2016-2026, Thousands
  • Table 31 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 32 : China Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 33 : China Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 34 : China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35 : China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36 : China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 37 : China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 38 : China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39 : China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40 : India Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 41 : India Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 42 : India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43 : India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44 : India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 45 : India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 46 : India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47 : India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48 : Japan Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 49 : Japan Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 50 : Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51 : Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52 : Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 53 : Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 54 : Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 55 : Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 56 : Australia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 57 : Australia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 58 : Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 59 : Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 60 : Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 61 : Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 62 : Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 63 : Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 64 : Indonesia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 65 : Indonesia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 66 : Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 67 : Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 68 : Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 69 : Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 70 : Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 71 : Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 72 : South Korea Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 73 : South Korea Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 74 : South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 75 : South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 76 : South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 77 : South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 78 : South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 79 : South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 80 : Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 81 : Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 82 : Western Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 83 : Western Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 84 : Western Europe Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 85 : Western Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 86 : Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 87 : Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 88 : Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 89 : Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 90 : Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 91 : Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 92 : UK Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 93 : UK Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 94 : UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 95 : UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 96 : UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 97 : UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 98 : UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 99 : UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 100 : Germany Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 101 : Germany Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 102 : Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 103 : Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 104 : Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 105 : Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 106 : Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 107 : Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 108 : France Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 109 : France Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 110 : France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 111 : France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 112 : France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 113 : France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 114 : France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 115 : France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 116 : Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 117 : Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 118 : Eastern Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 119 : Eastern Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 120 : Eastern Europe Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 121 : Eastern Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 122 : Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 123 : Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 124 : Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 125 : Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 126 : Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 127 : Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 128 : Russia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 129 : Russia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 130 : Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 131 : Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 132 : Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 133 : Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 134 : Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 135 : Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 136 : North America GDP Per Capita, By Country, 2016-2021, $
  • Table 137 : North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 138 : North America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 139 : North America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 140 : North America Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 141 : North America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 142 : North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 143 : North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 144 : North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 145 : North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 146 : North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 147 : North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 148 : USA GDP Per Capita, 2016-2021, $
  • Table 149 : USA Population By Age Group, 2016-2026, Thousands
  • Table 150 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 151 : USA Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 152 : USA Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 153 : USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 154 : USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 155 : USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 156 : USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 157 : USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 158 : USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 159 : South America GDP Per Capita, By Country, 2016-2021, $
  • Table 160 : South America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 161 : South America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 162 : South America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 163 : South America Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 164 : South America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 165 : South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 166 : South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 167 : South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 168 : South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 169 : South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 170 : South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 171 : Brazil Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 172 : Brazil Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 173 : Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 174 : Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 175 : Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 176 : Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 177 : Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 178 : Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 179 : Middle East GDP Per Capita, By Country, 2016-2021, $
  • Table 180 : Middle East Population By Age Group, By Country, 2016-2026, Thousands
  • Table 181 : Middle East Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 182 : Middle East Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 183 : Middle East Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 184 : Middle East Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 185 : Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 186 : Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 187 : Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 188 : Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 189 : Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 190 : Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 191 : Africa GDP Per Capita, By Country, 2016-2021, $
  • Table 192 : Africa Population By Age Group, By Country, 2016-2026, Thousands
  • Table 193 : Africa Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 194 : Africa Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
  • Table 195 : Africa Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 196 : Africa Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 197 : Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 198 : Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 199 : Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 200 : Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 201 : Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 202 : Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 203 : Vaccines Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 204 : Pfizer – Financial Performance, 2017– 2021, $ Billion
  • Table 205 : Merck & Co – Financial Performance, 2017– 2021, $ Billion
  • Table 206 : GlaxoSmithKline – Financial Performance, 2017 - 2021, $ Billion
  • Table 207 : Sanofi – Financial Performance, 2017– 2021, $ Billion
  • Table 208 : AstraZeneca – Financial Performance, 2017– 2021, $ Billion
  • Table 209 : Global Vaccine Market, Product Pipeline Analysis
  • Table 210 : Global Vaccines Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 211 : Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
  • Table 212 : Global Vaccines Market Size Gain ($ Million), Segmentation By Technology, 2021 – 2026
  • Table 213 : Global Vaccines Market Size Gain ($ Million), Segmentation By Route Of Administration, 2021 – 2026
  • Table 214 : Global Vaccines Market Size Gain ($ Million), Segmentation By Valence, 2021 – 2026
  • Table 215 : Global Vaccines Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026
  • Table 216 : Vaccines Market Data Sources
  • Figure 1 : Geographic Regions Covered
  • Figure 2 : Global Vaccines Market Segmentation By Type
  • Figure 3 : Global Vaccines Market Segmentation By Technology
  • Figure 4 : Global Vaccines Market Segmentation By Route Of Administration
  • Figure 5 : Global Vaccines Market Segmentation By Valance
  • Figure 6 : Global Vaccines Market Segmentation By Distribution Channel
  • Figure 7 : Global Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 8 : Global Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 9 : Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10 : Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11 : Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 12 : Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 13 : Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 14 : Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 15 : Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 16 : Asia-Pacific Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 17 : Asia-Pacific Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 18 : Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 19 : Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 20 : Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 21 : China Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 22 : China Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 23 : China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 24 : China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 25 : China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 26 : India Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 27 : India Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 28 : India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 29 : India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 30 : India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 31 : Japan Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 32 : Japan Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 33 : Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 34 : Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35 : Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 36 : Australia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 37 : Australia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 38 : Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 39 : Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 40 : Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 41 : Indonesia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 42 : Indonesia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 43 : Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 44 : Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 45 : Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 46 : South Korea Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 47 : South Korea Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 48 : South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 49 : South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50 : South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 51 : Western Europe Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 52 : Western Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 53 : Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 54 : Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 55 : Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 56 : UK Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 57 : UK Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 58 : UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 59 : UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 60 : UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 61 : Germany Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 62 : Germany Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 63 : Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 64 : Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 65 : Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 66 : France Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 67 : France Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 68 : France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 69 : France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 70 : France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 71 : Eastern Europe Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 72 : Eastern Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 73 : Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 74 : Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 75 : Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 76 : Russia Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 77 : Russia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 78 : Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 79 : Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 80 : Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 81 : North America Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 82 : North America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 83 : North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 84 : North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 85 : North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86 : USA Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 87 : USA Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 88 : USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 89 : USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 90 : USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 91 : South America Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 92 : South America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 93 : South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 94 : South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 95 : South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 96 : Brazil Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 97 : Brazil Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 98 : Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 99 : Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 100 : Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 101 : Middle East Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 102 : Middle East Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 103 : Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 104 : Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 105 : Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 106 : Africa Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 107 : Africa Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 108 : Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 109 : Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 110 : Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 111 : Vaccines Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Figure 112 : Pfizer – Financial Performance, 2017– 2021, $ Billion
  • Figure 113 : Merck & Co – Financial Performance, 2017– 2021, $ Billion
  • Figure 114 : GlaxoSmithKline – Financial Performance, 2017 – 2021, $ Billion
  • Figure 115 : Sanofi – Financial Performance, 2017– 2021, $ Billion
  • Figure 116 : AstraZeneca – Financial Performance, 2017– 2021, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Vaccines Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR595E

Including: 1) By Type: Single Antigen Vaccines; Combination Vaccines; Pediatric Vaccines; Adult Vaccines; Therapeutic Vaccines; Preventive Vaccines
2) By Technology: Conjugate Vaccines; Inactivated and Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines
3) By Route of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Others
4) By Valance: Monovalent; Multivalent
5) By Distribution Channel: Institutional Sale; Hospital Pharmacies; Retail Pharmacies
Covering: ...

Vaccines Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery

  • Date - Oct 2021
  • Code - TBR595D

Including: 1) By Type: Anti-Infective Vaccines; Anti-Cancer Vaccines; Others
2) By Technology: Conjugate Vaccines; Inactivated And Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines; Other Technologies
3) By Route of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Other Route of Administration
4) By Valance: Monovalent; Multivalent
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Institutional Sales
Covering: GlaxoSmithKline plc; ...

Vaccines Global Market Report 2021: COVID-19 Impact And Recovery To 2030

  • Date - Jun 2021
  • Code - TBR595C

Including: 1) By Type: Anti-Infective Vaccines; Autoimmunity; Others (Cancer And Others)
2) By Technology: Conjugate Vaccines; Inactivated and Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines
3) By Route of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Others
4) By Valance: Monovalent; Multivalent
5) By Distribution Channel: Institutional Sale; Hospital Pharmacies; Retail Pharmacies

Covering: AstraZeneca; Emergent Biosolutions; Glaxosmithkline; Merck; Pfizer 

...

Vaccines Global Market Report 2020-30: Covid 19 Impact and Recovery

  • Date - Oct 2020
  • Code - TBR595B

Including: 1) By Type: Anti-Infective Vaccines; Autoimmunity; Others (Cancer And Others)
2) By Technology: Conjugate Vaccines; Inactivated and Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines
3) By Route of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Others
4) By Valance: Monovalent; Multivalent
5) By Distribution Channel: Institutional Sale; Hospital Pharmacies; Retail Pharmacies

Covering: AstraZeneca; Emergent Biosolutions; Glaxosmithkline; Merck; Pfizer 

...

Vaccines Global Market Report 2020

  • Date - Dec 2019
  • Code - TBR595A

Including: 1) By Type: Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others) 2) By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines 3) By Route of Administration: Intramuscular (IM), Subcutaneous (SC), Oral, Others 4) By Valance: Monovalent, Multivalent 5) By Distribution Channel: Institutional Sale, Hospital Pharmacies, Retail Pharmacies
Covering: AstraZeneca, Emergent Biosolutions , Glaxosmithkline , Merck , Pfizer 

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS